As World Asthma Day (May 3) approaches, experts outline the growing problem of asthma and lung diseases as a result of air pollution.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure.
In support of World Asthma Day, May 3, the Forum of International Respiratory Societies (FIRS) is calling for more collaborative action in asthma treatment.
The US FDA has approved Bevespi Aerosphere inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with COPD.
An article in Anesthesia & Analgesia presents a review and update for hospital-based providers who may encounter vaccine-preventable diseases (VPDs).
A new therapy targets the body's vascular response to sepsis as opposed to the infection itself or the body's inflammation response and has shown positive results in murine studies.
Yale scientists identified a common genetic network for COPD and pulmonary fibrosis that could inform both future research and drug development.
A new study finds a large number of individual sites within the lungs undergo active disease scarring in pulmonary fibrosis.
The new website provides greater insight into Nihon Kohden’s products that help professionals across the healthcare system improve the quality of care while controlling costs.
By 2050, some parts of the US, and especially California, the Southwest and the Northeast, could be experiencing up to 9 extra days a year of unhealthy ozone levels.
Memorial Hermann-Texas Medical Center recently announced its new Lung Transplant Program, which offers lung and all solid organ transplants.
According to a report by The Hill, the House Appropriations Committee voted Tuesday to exempt all electronic cigarettes and cigars currently on the market from rules proposed by the FDA.
The US FDA is expanding its “The Real Cost” campaign to educate rural, white male teens about the negative health consequences associated with smokeless tobacco use.
RT consulted with some leading device manufacturers about today’s airway clearance products and the industry and technology trends in the next few years.
Several types of aerosol delivery technology exist on the market today, but depending on the specific disease being treated, certain devices may make more sense for patients.
Cigarette smoking and infection with viruses such as influenza can reduce the effectiveness of symptom-reliever drugs like salbutamol in patients with COPD.
High-volume lung transplant centers have lower transplantation costs and their patients are less likely to be readmitted within 30 days of leaving the hospital following surgery.
Bronchial thermoplasty is equally effective in improving the quality of life of severe refractory asthmatics regardless of the demographic factors associated with their healthcare disparities.
Firefighters who responded in the first two days of the World Trade Center disaster and those who worked at the site for six months or longer are more likely to need sinus surgery.
CSA Medical Inc has initiated treatments in a clinical study to evaluate the safety and feasibility of treating chronic bronchitis patients with the RejuvenAir System, a "cryotherapy" spray that freezes and ablates unwanted tissue inside the lungs.